Blood Test to Measure DNA Damage in Blood
NCT00523471 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2016-02-26
Summary
To check the radiosensitivity level in individual patients based on their DNA damage level.
Conditions
Interventions
- PROCEDURE
-
Blood test
Sponsors & Collaborators
-
AHS Cancer Control Alberta
lead OTHER
Principal Investigators
-
Nadeem Pervez, MBBS, FRCPC · AHS Cancer Control Alberta
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
NCT07109427 ·Status: RECRUITING ·Phase: NA
-
Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients
NCT01488968 ·Status: TERMINATED ·Phase: NA
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer
NCT07291557 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer
NCT04733768 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer
NCT00045331 ·Status: COMPLETED ·Phase: NA
-
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
NCT00898274 ·Status: COMPLETED
-
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
NCT07234981 ·Status: RECRUITING ·Phase: PHASE2
-
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
NCT06122584 ·Status: RECRUITING ·Phase: PHASE3
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer
NCT05328505 ·Status: RECRUITING ·Phase: NA
-
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
NCT04557501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer
NCT05313815 ·Status: RECRUITING ·Phase: NA
-
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
NCT04742361 ·Status: COMPLETED ·Phase: PHASE3
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING
-
PSMA-Guided Ablation of the Prostate
NCT06003556 ·Status: RECRUITING ·Phase: PHASE2
-
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer
NCT04067713 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer
NCT05333432 ·Status: WITHDRAWN ·Phase: NA
-
Diagnostic Accuracy and Performance of 18F-PSMA-1007
NCT04986280 ·Status: COMPLETED
-
Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer
NCT05681416 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
NCT03494803 ·Status: WITHDRAWN
-
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer
NCT05712174 ·Status: TERMINATED ·Phase: PHASE2
-
DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine
NCT06347809 ·Status: TERMINATED
-
Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer
NCT00126165 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
NCT05799248 ·Status: RECRUITING ·Phase: PHASE3